कृपया अन्य खोज का प्रयास करें
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson’s program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Chuan He | 51 | - | Member of Scientific Advisory Board |
Michael G. Kaplitt | - | - | Member of Scientific Advisory Board |
Nicole Seligman | 67 | 2019 | Independent Director |
Gregory A. Petsko | - | - | Chairman of Scientific Advisory Board |
Keith Reginald Harris | 70 | 2015 | Independent Chairman of the Board |
Arnold J. Levine | 83 | 2016 | Member of Scientific Advisory Board |
James C. Alwine | - | - | Member of Scientific Advisory Board |
Alexandria Forbes | 58 | 2015 | CEO, President & Director |
Kevin Weeks | - | - | Member of Scientific Advisory Board |
Brian Shoichet | - | - | Member of the Scientific Advisory Board |
Martin Indyk | 71 | 2019 | Independent Director |
Debra Yu | 58 | 2022 | Independent Director |
Stefano Rivella | - | - | Member of Scientific Advisory Board |
Thomas E. Shenk | 76 | 2015 | Independent Director & Member of Scientific Advisory Board |
Neil Mendoza | 63 | 2015 | Independent Director |
Lynne Elizabeth Maquat | - | 2019 | Member of Scientific Advisory Board |
Robert Batey | - | - | Member of Scientific Advisory Board |
Ellen Hukkelhoven | 36 | 2017 | Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है